Epstein Secrets

"Moment Of Truth." In a column for the Washington Pnst (10/22, 14.2M) entitled, "Can Trump's Spy Chief Be Trusted?," David Ignatius writes that DNI Ratcliffe's performance "has often seemed to emphasize...serving the political interests of the man who appointed him, President Trump." The President "is des

Wyden Urge FBI Not To Probe Biden Family Prior To Election. • Ex-Hunter Biden Partner Says Joe Biden Was Set To Get Cut Of Business Deal. • Trump, Ratcliffe Reportedly Seeking Declassification Of Russia Inquiry Document. • John Brennan Discusses DNI Ratcliffe's "Credibility," Trump's Relationship With In

WHO study, which was not 'blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

"Moment Of Truth." In a column for the Washington Post (10/22, 14.2M) entitled, "Can Trump's Spy Chief Be Trusted?," David Ignatius writes that DNI Ratcliffe's performance "has often seemed to emphasize...serving the political interests of the man who appointed him, President Trump." The President "is des

Wyden Urge FBI Not To Probe Biden Family Prior To Election. • Ex-Hunter Biden Partner Says Joe Biden Was Set To Get Cut Of Business Deal. • Trump, Ratcliffe Reportedly Seeking Declassification Of Russia Inquiry Document. • John Brennan Discusses DNI Ratcliffe's "Credibility," Trump's Relationship With In

WHO study, which was not `blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

ector of National Intelligence John Ratcliffe's May confirmation hearings, he had "promised to provide the report within months." A spokesperson for Ratcliffe "told the I-Team 'he followed through with this commitment in good faith' by sending letters in July to the House and Senate committees offering to

. Bloomberg <https://www.bloomberg.com/news/articles/2020-09-22/pfizer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

Wyden Urge FBI Not To Probe Biden Family Prior To Election. • Ex-Hunter Biden Partner Says Joe Biden Was Set To Get Cut Of Business Deal. • Trump, Ratcliffe Reportedly Seeking Declassification Of Russia Inquiry Document. • John Brennan Discusses DNI Ratcliffe's "Credibility," Trump's Relationship With In

used." Bloomberg <https://www.bloomberg.cotn/news/articles/2020-10-22/gilead-virus-therapy-remdesivir-gains- approval-from-fda?srnd-premium> (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

ector of National Intelligence John Ratcliffe's May confirmation hearings, he had "promised to provide the report within months." A spokesperson for Ratcliffe "told the I -Team 'he followed through with this commitment in good faith' by sending letters in July to the House and Senate committees offering t

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

ector of National Intelligence John Ratcliffe's May confirmation hearings, he had "promised to provide the report within months." A spokesperson for Ratcliffe "told the I -Team `he followed through with this commitment in good faith' by sending letters in July to the House and Senate committees offering t

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo